|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
University of Rochester Medical Center
1 E-mail: toru_takimoto{at}urmc.rochester.edu
Human parainfluenza virus type 1 (hPIV1) and Sendai virus (SeV) are highly homologous in structure and sequence, while maintaining distinct host ranges. These viruses express accessory proteins from their P/C gene, which are known to have anti-innate activities. The accessory proteins expressed from the P/C genes are different between these viruses. In addition to the nested set of C proteins, SeV expresses V protein from edited P mRNA, which is not expressed by hPIV1. In this study, we evaluated the host specificity and role of P/C gene products in anti-IFN and anti-apoptosis activity by characterizing a recombinant SeV, rSeVhP, in which the SeV P/C gene was replaced with that of hPIV1. Unlike SeV, rSeVhP infection strongly activated IRF-3 and NF-
B, resulting in an increased level in IFN-β induction compared to SeV in murine cells. In contrast, activation of IRF-3 was not observed in rSeVhP-infected human A549 cells. rSeVhPSV, which expresses SeV V protein from an inserted gene in rSeVhP induced less IFN-β than rSeVhP, suggesting V contributes to suppression of IFN production in murine cells. Furthermore, rSeVhP induced apoptotic cell death in murine but not in A549 cells. These data indicate the functional difference of P/C gene products from SeV and hPIV1 in antagonizing IFN induction and apoptosis, which is likely to be one of the major factors for pathogenicity to specific hosts.
Received 9 March 2009;
accepted 23 April 2009.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |